Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Microbes and Infection|September 22, 2020
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector systemNina Marí G P de Queiroz, Fabio V Marinho, Marcelo A Chagas, et al.
Infection and Immunity|March 3, 2010
The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent miceCyntia G M C Trant, Thais L S Lacerda, Natalia B Carvalho, et al.
Plos One|July 26, 2016
Schistosoma mansoni Tegument (Smteg) Induces IL-10 and Modulates Experimental Airway InflammationFábio Vitarelli Marinho, Clarice Carvalho Alves, Sara C de Souza, et al.
The Journal of Investigative Dermatology|December 17, 2017
IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous LeishmaniasisDaniela Santos, Taís M Campos, Maíra Saldanha, et al.
Frontiers in Cellular and Infection Microbiology|November 1, 2012
The role of innate immune signals in immunity to Brucella abortusMarco Túlio R Gomes, Priscila C Campos, Leonardo A de Almeida, et al.
Frontiers in Immunology|August 15, 2018
Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in MiceSuellen B Morais, Barbara C Figueiredo, Natan R G Assis, et al.
Pathogens (Basel, Switzerland)|January 25, 2025
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 VariantsFábio Mambelli, Ana Carolina V S C de Araujo, Jéssica P Farias, et al.
Plos Neglected Tropical Diseases|March 22, 2014
Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infectionVicente P Martins, Suellen B Morais, Carina S Pinheiro, et al.
Infection and Immunity|March 6, 2013
Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in miceLeonardo A de Almeida, Gilson C Macedo, Fábio A V Marinho, et al.
Tuberculosis (Edinburgh, Scotland)|April 6, 2019
JVA, an isoniazid analogue, is a bioactive compound against a clinical isolate of the Mycobacterium avium complexJúlia S Fahel, Rafael P Vieira, Fábio V Marinho, et al.
Pageof 12